Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Mutation
Clinical trial NCT00893399 · COMPLETED
Trial details
- NCT number
- NCT00893399
- Sponsor
- University of Ulm
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-12
- Primary completion
- 2021-09-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.